♣ Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients.

Citation:
AN, A. N. Z., D. Abdullah, A. Osman, E. - R. M. N. MN, N. Zayed, G. Esmat, E. W. W, and H. A. Hafez, "♣ Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients. ", .Arab J Gastroenterol. , vol. September–December 2015; 16, issue (3-4), pp. 84–89, 2015.